Autonomix Medical Q2 FY26 net loss narrows 18.18% to $2.7 million
Reuters2026/08/13 10:04- Autonomix Medical posted a GAAP net loss of USD 2.7 million for the quarter ended June 30, 2026.
- Total operating expenses fell 19% to USD 2.77 million, led by a 31% drop in general and administrative costs to USD 1.26 million.
- Research and development spending edged down 5% to USD 1.52 million.
- Cash totaled USD 3.5 million, with working capital of USD 3.1 million; cash runway is expected into but not beyond Q1 2027.
- In July, Nasdaq bid-price compliance was regained; a warrant inducement brought about USD 2.6 million in gross proceeds.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
